A1BG | Alpha-1-B glycoprotein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
A1CF | APOBEC1 complementation factor | | | | | | Tissue enhanced |
A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
AAAS | Achalasia, adrenocortical insufficiency, alacrimia | Disease related genes
| | | | | Expressed in all |
AACS | Acetoacetyl-CoA synthetase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AADAC | Arylacetamide deacetylase | Enzymes
| | | | | Tissue enhanced |
AADAT | Aminoadipate aminotransferase | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
AAGAB | Alpha- and gamma-adaptin binding protein | Disease related genes
| | | | | Expressed in all |
AAK1 | AP2 associated kinase 1 | Enzymes
| | | | | Expressed in all |
AAMDC | Adipogenesis associated, Mth938 domain containing | | | | | | Expressed in all |
AAMP | Angio-associated, migratory cell protein | Plasma proteins
| | | | | Expressed in all |
AANAT | Aralkylamine N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
AAR2 | AAR2 splicing factor homolog (S. cerevisiae) | | | | | | Expressed in all |
AARS | Alanyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
AARS2 | Alanyl-tRNA synthetase 2, mitochondrial | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
AARSD1 | Alanyl-tRNA synthetase domain containing 1 | | | | | | Expressed in all |
AASDH | Aminoadipate-semialdehyde dehydrogenase | Predicted membrane proteins
| | | | | Expressed in all |
AASDHPPT | Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | | | | | | Expressed in all |
AASS | Aminoadipate-semialdehyde synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Mixed |
AATF | Apoptosis antagonizing transcription factor | | | | | | Expressed in all |
AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA12 | ATP-binding cassette, sub-family A (ABC1), member 12 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCA2 | ATP-binding cassette, sub-family A (ABC1), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB10 | ATP-binding cassette, sub-family B (MDR/TAP), member 10 | Mitochondrial proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB6 | ATP-binding cassette, sub-family B (MDR/TAP), member 6 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC10 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC12 | ATP-binding cassette, sub-family C (CFTR/MRP), member 12 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |